Expertise: Innovation Centers
Arturo Molina, M.D., M.S. F.A.C.P. is Vice President, Oncology Scientific Innovation at Janssen Research & Development, LLC. He represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, California, based in Menlo Park. In this role, he is responsible for identifying and fostering innovation in the region that supports the Oncology Therapeutic Area strategies.
Previously Arturo was Vice President, Clinical Research, Oncology, where he was responsible for the clinical development and registration-directed studies of the company’s treatment for metastatic castration-resistant prostate cancer. Prior to this role, he was the Chief Medical Officer and Executive Vice-President at Cougar Biotechnology, which was acquired by the Johnson & Johnson Family of Companies.
Before joining Cougar Biotechnology, Arturo worked at IDEC as Senior Director, Medical Affairs, ultimately becoming Department Head, Oncology Clinical Development for Biogen Idec Inc. In collaboration with Genentech, he led clinical supplemental biologics license application filing activities resulting in the United States Food and Drug Administration approval of a treatment for chronic lymphocytic leukemia. He was a faculty staff physician in Hematology/Bone Marrow Transplantation and Medical Oncology/Therapeutics Research at the City of Hope (COH) Comprehensive Cancer Center in California, where he became an adjunct professor and member of the COH Medical Group Board of Directors.
Arturo received his medical degree and master’s in physiology from Stanford University School of Medicine in California, and continued at Stanford for residency in internal medicine and fellowships in medical oncology, biological science and bone marrow transplantation. Arturo was an undergraduate at the University of Texas at Austin, where he received bachelors’ degrees in zoology (honors) and psychology (high honors).